Gangliosides are the most complex oligosaccharide-containing glycosphingolipids defined by the presence of sialic acid and although present in all tissues, predominate in the brain. Considering their importance in neural development, it is unsurprising that ganglioside metabolism is altered in neurodegenerative diseases. The severe form of mucopolysaccharidosis type I, Hurler syndrome (HS), is characterised by progressive loss of neuronal function through largely undefined mechanisms. Here, we sought to interrogate brain gangliosides in a murine model of HS and further, assessed whether dietary modulation of lipid metabolism effected correction of the metabolic abnormalities. The simple gangliosides, G M2 , G M3 , G D2 and G D3 were elevated in the five subregions examined -brain stem, cerebellum, cortex, hippocampus, subcortex -in HS mice as early as 2 months of age compared with their wild type counterparts. Their elevation persisted at 6 months of age, imparting protracted neurological development as these simple gangliosides have usually subsided by this stage of brain development. Their immediate synthetic precursor, lactosylceramide, was also elevated, suggesting that their increase arises at this metabolic intermediary, as dihydroceramide, ceramide and monohexosylceramide were unaffected. Dietary linoleic acid supplementation significantly reduced G M2 and G M3 , and furthermore, improved exploratory behaviour as assessed by the open field test, highlighting the possibility of further exploring dietary intervention as a therapeutic consideration. Keywords: gangliosides, inborn error of metabolism, linoleic acid, mouse model, neurological disease, tandem mass spectrometry.
Mucopolysaccharidosis type I is an autosomal recessive metabolic disorder arising from an absolute or functional deficiency of the lysosomal enzyme a-L-iduronidase requisite for the catabolism of the glycosaminoglycans, heparan sulphate and dermatan sulphate. Consequently, these partially degraded glycosaminoglycans accumulate in affected cells leading to the chronic and progressive deterioration of cells, tissues and organs resulting in multiple organ failure (Neufeld and Muenzer, 2001) . Although enzyme replacement therapy is effective in reducing organomegaly, with a molecular weight of 87 kDa, recombinant a-L-iduronidase is too large to cross the blood-brain barrier rendering it unhelpful for the relentless neurodegeneration inherent in the severe form of mucopolysaccharidosis type I, Hurler syndrome (HS) (Sifuentes et al. 2007 ). Accordingly, neurological disease manifests progressive neurocognitive decline in infancy leading to death in late childhood, for which there is no treatment.
A knock-out murine model of HS, created by targeted disruption of a-L-iduronidase, exhibits a progressive clinical course (Clarke et al. 1997; Russel et al. 1998) . Functional neurocognitive assessments in this model have demonstrated hypoactivity as early as two months of age in a new environment, which fails to decrease with habituation (Reolon et al. 2006; Pan et al. 2008) . Memory and learning tasks have not been so clearly defined with some reporting impairment in older HS mice (Wolf et al. 2011) and others reporting no differences (Baldo et al. 2013) . Histopathological and immunohistochemical examinations reveal enlarged lysosomes in the neurons, microglia and perivascular space that progress over time. Glia activation and astrocytosis, evidence of chronic neuroinflammation, is apparent as early as four months of age, indicating that this process starts reasonably early in life. Further support for an inflammatory process is highlighted by the presence of chemokines in the brain of HS mice (Ohmi et al. 2003; Wilkinson et al. 2012) . However, how these findings relate to the severe neurological decline manifest in the human equivalent of the disease remains unclear.
Excess accumulation of heparan sulphate in HS, as well as in mucopolysaccharidosis types III and VII, has been suggested to be partly responsible for the secondary storage of G M2 and G M3 gangliosides (McGlynn et al. 2004; Walkley and Vanier 2009) . Indeed, elevated G M2 and G M3 have been shown not only in the HS mouse (Russel et al. 1998) but also in brain tissue from HS patients at autopsy (Constantopoulos et al. 1980) . Although considered a marker of neurodegeneration, no exact function has been attributed to gangliosides in this process. Distinguished from other glycosphingolipids by extensive carbohydrate with sialic acid (Fig. 1) , gangliosides are abundant in the brain and play important roles in development (Yu et al. 2004) . Their involvement in neurodegeneration is therefore not unexpected, but what precipitates some gangliosides to be elevated in HS and others to remain unaltered and, moreover, what role they play in the neurological manifestations of HS is still unclear. We hypothesised that there were subregional differences in gangliosides in the HS brain which could be alleviated by dietary intervention with concomitant improvement in neurobehaviour. To test this hypothesis, we interrogated ganglioside metabolism in the brain of the well-characterised murine model of HS (Clarke et al. 1997; Saville et al. 2016 ) and sought to evaluate whether dietary fatty acid supplementation was able to impact metabolism thereby reducing secondary ganglioside accumulation. Complicit improvements in locomotor activity and exploratory behaviour were measured in the open field test.
Materials and methods

Mice
The HS mouse model (Idua À/À , C57BL/6 background) was purchased from the Jackson Laboratory (Bar Harbour, ME, USA) and all animal protocols were approved by the Women's and Children's Health Network Animal Ethics Committee. One week prior to mating, heterozygous breeding pairs were placed on one of four diets: docosahexaenoic acid (DHA), SF07-021 Modified AIN93G Rodent Diet 7% fish oil; linoleic acid (LA), SF07-022 Modified AIN93G Rodent Diet 7% safflower oil; high fat (HF), AIN93G Rodent fat matched with SF07-021 and SF07-022 and Reg (regular), meat-free rat and mouse diet (diets supplied by Specialty Feeds, Glen Forrest, WA, Australia). Offspring were genotyped (Clarke et al. 1997 ) following weaning at 3 weeks of age and 10 wild type (WT) and 10 HS mice continued on each of the respective diets with the exception of the Reg diet, which included 15 HS and 15 WT mice. Mice were group housed (3-5 mice per cage) according to diet on a 14/10 h light/dark cycle in a temperature controlled facility (22°C) and allowed ad libitum food and water. The male to female ratio for each diet was: Reg, WT, 8 : 6, HS, 5 : 10; LA, WT, 6 : 4, HS, 4 : 6; DHA, WT, 6 : 4, HS, 5 : 5; HF, WT, 3 : 7, HS, 7 : 3.
Study design
Sample size and power calculations -performed in SigmaStat 3.0 (power = 0.8, ɑ = 0.05) -dictated a sample size of five for lipid analysis and eight for the open field testing. In the case of an unexpected/unexplained death of one of the animals, 10 mice were estimated for the 6-month time frame with the exception of the HS mice on the Reg diet (n = 9) in which one female mouse did indeed unexpectedly die. Heterozygous breeding pairs were assigned to one of the four (Reg, LA, DHA and HF) diets 1 week prior to mating to allow continual exposure to the fatty acids throughout neuronal development, including the gestational period, which may be critical for the development of secondary storage. At 2 months of age, five (three male and two female) WT and five (zero male and five female) HS on the Reg diet were killed, and the remaining 10 WT and 10 HS mice on all four diets (as mentioned above nine HS mice on the Reg diet) underwent open field testing at 2, 4 and 6 months of age and were then also killed by CO 2 asphyxiation (at 6 months). The brains were removed and the brain stem, cerebellum, cortex, hippocampus and subcortex dissected, snap frozen in liquid nitrogen and stored at À70°C prior to lipid extraction. Figure 2 depicts a schematic of the experimental design. True blinding of the mice was not possible because of the nature of the diets (different smell and texture) and the obvious physical differences manifest between the WT and HS mice. However, the mice were identified by a number hence the operator performing the open field test was blinded as to the diet, but not phenotype. As mice were group housed, it was not possible to monitor individual food consumption for each mouse, although no noticeable differences were recorded between the different diets when food was replenished. Furthermore, there were no dietary associations with body weight at 6 months of age with both the male and female HS mice significantly heavier than the WT mice on the Reg diet as previously reported (Saville et al. 2016) .
Total single phase lipid extraction Each brain region was resuspended in 0.02 M Tris (pH 7) containing 0.5 M NaCl and 0.1% Nonidet P-40 (109 volume per weight) and Dounce homogenised on ice. Total protein was determined by the method of Lowry et al. (1951) and 0.1 mg in 0.01 mL was extracted with the addition of 0.2 mL of CHCl 3 : CH 3 OH (2 : 1) containing 1 pmol of sphingosine d17:1 {D-erythro-sphingosine (C17 base)}, 5 pmol of dihydroceramide (dhCer) d18:0/8:0 {N-octanoyl-D-erythro-sphinganine}, 10 pmol of ceramide (Cer) d18:1/17:
:1/18:0 (ammonium salt)} and 1 nmol of cholesterol (d 7 ) (DHC, MHC and G M1 (d 3 ) were from Matreya LLC, State College, PA, USA all other lipids were from Avanti Polar Lipids, Alabaster, AL, USA), as internal standards. Following a brief vortex, samples were mixed on a rotary mixer for 10 min, sonicated in a water bath for 30 min and then allowed to stand at 23°C for 20 min. The protein was sedimented Fig. 1 Partial schematic of glycosphingolipid synthesis. The structure of ceramide, from which the glycosphingolipids are synthesised, is shown with a sphingosine (d18:1) backbone and R denoting the fatty acid. s, galactose; 4, glucose; h, Nacetylgalactosamine; e, sialic acid; 5, sulfate; Cer, ceramide; GalCer, galactosylceramide and GluCer, glucosylceramide (both defined as MHC, monohexosylceramide);
LacCer, lactosylceramide (denoted as DHC, dihexosylceramide); THC, trihexosylceramide; G M , G D , G T , G Q , mono-, di-, tri-and tetrasialogangliosides, respectively. by centrifugation at 13 000 g for 10 min, the supernatant removed and dried under a gentle stream of nitrogen at 40°C. Dried samples were stored at À20°C until analysis by liquid chromatography-electrospray ionisation-tandem mass spectrometry (LC-ESI-MS/MS).
LC-ESI-MS/MS
The lipid extract was reconstituted in 0.1 mL of CH 3 OH containing 10 mM NH 4 COOH and for sphingolipid analysis 1 lL was injected onto a Zorbax Eclipse C18, 2.1 9 50 mm column maintained at 40°C (CTO-30A oven), using a Shimadzu Nexera x2 SIL-30AC autosampler maintained at 16°C configured with LC 30 AD pumps. An Agilent 1290 inline filter containing a 0.3 lm frit was placed in front of the column. Solvent A was 60% H 2 O, 40% CH 3 CN containing 10 mM NH 4 COOH and solvent B was 90% (CH 3 ) 2 CHOH, 10% CH 3 CN containing 10 mM NH 4 COOH. At injection, mobile phase conditions were 90% solvent A and 10% solvent B, which was linearly ramped to 50% by 2 min and then to 100% solvent B at 8 min. This was held for 0.5 min followed by a return to 90% solvent A at 9 min, which was equilibrated for 1 min prior to the next injection. The flow rate was 0.4 mL/min. For the first minute, column flow was diverted to waste and then directly into the electrospray source (ES 5500 V) of an AB SCIEX QTRAP 6500 triple quadrupole tandem mass spectrometer with an ion source temperature of 250°C. Nitrogen was used for curtain gas, 25 units; collision gas set at medium; nebulizer gas 1, 20 units and auxillary gas 2, 40 units. Individual species of sphingosine, dhCer, Cer, DHC, MHC, THC, sulfatide and cholesterol were quantified, using scheduled multiple reaction monitoring in positive ion mode (Table S1 ). Concentrations of each molecular species were calculated by relating the peak areas of each species to the peak area of the corresponding internal standard (with sulfatides related to the THC internal standard), using MultiQuant 3.0.1 software (AB SCIEX, Framingham, MA, USA).
For ganglioside analysis, 5 lL of lipid extract was injected onto the column and mobile phase A and B were as described above for sphingolipid analysis except 0.05% NH 4 OH replaced NH 4 COOH to ensure the larger gangliosides (MW > 1000 Da) could be quantified as doubly charged ions. At injection, mobile phase conditions were 90% solvent A and 10% solvent B, which was linearly ramped to 30% B by 5 min, 60% B by 8 min and then to 100% B at 10.5 min. This was held for 0.5 min followed by a return to 10% B at 11 min, which was equilibrated for 1 min prior to the next injection. Source parameters were as follows: IS, À4500 V, curtain gas, 25 units; collision gas, high; nebulizer gas 1, 20 units and auxillary gas 2, 45 units. Individual species of gangliosides were quantified, using non-scheduled multiple reaction monitoring (Table S1 ) in negative ion mode and concentrations were calculated by relating the peak areas of each species to the peak area of G M1 d18:1/18:0 (d 3 ) using MultiQuant 3.0.1 software.
Open field
Locomotor activity and exploratory behaviour was monitored, using an automated activity monitoring system (Harvard apparatus, Holliston, MA, USA). Each mouse was placed individually in the left corner of an open field arena (40 9 40 cm) and allowed to explore freely for 3 min. The ratio of distance in the centre and ratio of time in the centre expressed as a percent of total were recorded. Animals were repeat tested at 2, 4 and 6 months of age.
Statistical analyses
Differences between HS and WT were analysed for significance, using a two-tailed Student's t-test following an F-test for homoscedastic variance. Pearson's correlation coefficients between individual lipid species and the five brain regions were also determined, using SPSS version 15.0 (IBM, Armonk, NY, USA) for Windows statistics software.
Results
Regional brain gangliosides
The individual acyl chain species of G D1 , G D2 , G M1 , G M2 and G M3 that were quantified are reported in Table S1 and a schematic of their metabolism and structures depicted in Fig. 1 . All species correlated within each ganglioside class (Pearson's correlation > 0.8) and the d18:1/18:0 was the most prominent isoform. The G M1 and G D1 were clearly the most abundant gangliosides in the brain comprising > 90% in both the WT and HS brain regions. G M1 was significantly elevated in the cerebellum of the HS mice at 2 and 6 months of age, but there was no significant elevation in the other brain regions (Fig. 3) . There was no difference in the concentrations of G D1 between HS and WT and the concentrations were similar at 2 and 6 months of age (data not shown).
In contrast, there was widespread elevation in G M2 , G M3 , G D2 and G D3 in all five brain regions of HS mice compared with WT as early as 2 months of age. This elevation was maintained at 6 months of age with no further increase (Fig. 4) . Dietary supplementation of LA was able to significantly reduce G M2 in the HS mice in all brain regions except the cerebellum, and G M3 with the exception of the cerebellum and the hippocampus (p < 0.07), however there were no reductions in G D2 or G D3 (Fig. 4) . The HF diet significantly increased G D2 and G D3 concentrations in both HS and WT mice (Fig. 5 ) but had no effect on G D1 , G M2 or G M3 concentrations. The effect of the DHA diet on ganglioside concentration in both HS and WT mice was unremarkable (data not shown).
Regional brain synthetic precursors
As gangliosides are synthesised from lactosylceramide originating from sphingolipid precursors (Fig. 1) , we next determined the concentrations of dhCer, Cer, MHC, DHC and THC in the brain regions of the HS and WT mice. Table 1 shows there were no significant differences in the concentrations of dhCer, Cer, MHC as well as cholesterol, between the HS and WT brain regions at 2 or 6 months, and THC was not detected in the brain. Two species of sphingosine (d18:1 and d20:1) were summed and Table 1 shows that this lipid was also present at similar concentrations in HS and WT mice. DHC was elevated in all five brain regions of the HS mice compared with WT at 2 months of age and this same elevation was present at 6 months. All six isoforms of DHC was elevated in the brain regions of the HS mice compared with WT at 2 and 6 months of age. Figure 6 depicts the elevation of the 18:0 species, which was the most abundant comprising 90% of the total DHC. Figure 7 shows that dietary supplementation of LA reduced DHC in the HS mouse model in all brain regions, except the cortex, although this reduction was not significant in the hippocampus (p = 0.07). There was no significant reduction in DHC in the WT mice. The LA, HF and DHA diets had no impact on the concentrations of dhCer, Cer, MHC, DHC, THC, Fig. 4 G M2 , G M3 , G D2 and G D3 concentrations in brain subregions from mice on the regular (Reg) and linoleic acid (LA) diet at 6 months of age. Total G M2 , G M3 , G D2 and G D3 concentrations were determined by summing d18:1/18:0 and d18:1/20:0 for G M2 and G D2 , and summing d18:1/18:0, d18:1/20:0 and d18:1/22:0 for G M3 and G D3 . Concentrations are expressed as the mean AE SEM with wild type (WT) and Hurler syndrome (HS) mice on the Reg diet represented by open and filled bars, respectively. WT and HS mice on the LA diet are depicted with horizontal and diagonal striped bars, respectively. BS, brain stem; C, cortex; CB, cerebellum; H, hippocampus; SC, subcortex. **p < 0.01, *p < 0.05; n = 6. cholesterol and sphingosine (data not shown). As sulfatides are also synthesised from ceramide ( Fig. 1) , we assessed whether there were any differences in concentration between the HS and WT mice and Table 1 shows that sulfatide was unremarkable and similar to the aforesaid sphingolipids, not influenced by diet. 
Motor activity
In the open field test, locomotor and exploratory activity of the HS mice was reduced compared with WT mice (Fig. 8) .
Although there was an expected reduction with age (from 2 to 6 months) in both WT and HS mice, the HS mice in receipt of the LA diet did not decline with age. The most dramatic results were seen in the ratio of the time in the centre whereby the HS mice on the LA, by 6 months of age, significantly outperformed the HS mice on the Reg diet. There was also a trend in improvement with the ratio of centre distance but this did not reach significance (p = 0.12). Of note was a significant increase in the ratio of centre time for the HS mice on the LA diet compared with the WT mice on the Reg diet at 6 months of age. There was no difference in WT and HS mice on the DHA or HF diet when compared with the Reg diet (data not shown).
Discussion
The pattern of ganglioside expression is tightly regulated during neurodevelopment (Ngamukote et al. 2007 ). In the early embryonic brain of vertebrates, the simple gangliosides G M3 and G D3 predominate. As the brain develops, the expression of these simple gangliosides diminishes along with a concomitant increase in the more complex gangliosides (Sturgill et al. 2012) . G M1 , G D1 and G T1 emerge as the dominant gangliosides during the succeeding stages of neurodevelopment, suggesting that the temporal regulation of ganglioside expression reflects their functional roles at particular stages of development (Yu et al. 2009 ). As expected the complex gangliosides, G M1 and G D1 , predominated in the brain of the mice at both 2 and 6 months of age, consistent with later stage of brain development. These complex gangliosides were generally preserved in the HS mice with elevation in G M1 only seen in the cerebellum when compared with WT mice (Fig. 3) . As expected for the developed brain, the simpler gangliosides, G M2 , G M3 , G D2 and G D3 , were present at much lower levels than the complex gangliosides at 2 and 6 months of age. Although still minor components of the HS brain, the increase in these gangliosides compared with WT (Fig. 4) may suggest that neurodevelopment is retarded in the HS brain as the presence of the simpler gangliosides persist. The change in pattern of ganglioside expression in the developing brain has been largely attributed to the temporal regulation of enzymes responsible for their synthesis, namely ganglioside synthases (Yu et al. 2008) . Earlier work suggested that reduced neuraminidase activity was responsible for the elevations of at least some of the simple gangliosides in HS (Walkley 2004) , but more recently a combined effect of ganglioside synthesis and degradation has been implicated. Both reduced neuraminidase activity together with reduced G D3 and G M2 /G M3 synthase activity were deemed responsible Fig. 7 Effect of linoleic acid diet on subregional dihexosylceramide (DHC). Total DHC was determined by summing the six species measured and is expressed as the mean concentration AE SEM in the brain stem (BS), cortex (C), cerebellum (CB) hippocampus (H) and subcortex (SC). Open bars represent wild type (WT) and filled bars Hurler syndrome (HS) on the Reg diet. WT and HS mice on the linoleic acid diet are depicted with horizontal and diagonal striped bars, respectively. *p < 0.05; n = 6 (significance shown for diet comparisons only). The ratio of time spent in the centre and the ratio of distance travelled in the centre expressed as a percent of total. Open bars represent WT and filled bars HS on the Reg diet. WT and HS mice on the linoleic acid diet are depicted with horizontal and diagonal striped bars, respectively. **p < 0.01, *p < 0.05; n = 10 (except Reg diet n = 9).
for the regional elevations in gangliosides in the HS brain (Kreutz et al. 2013) . Our results support these findings of elevations in G M2 , G M3 and G D3 in the hippocampus, as well as a demonstrated elevation in G M1 in the cerebellum and cortex, noting a difference in the methodology, mass spectrometry used in this study being more specific and quantitative than thin layer chromatography (TLC) used by Kreutz et al. (2013) . The gangliosides were generally congruent between the brain stem, cortex, cerebellum, hippocampus and subcortex, with the 18:0 acyl species predominating in each class of ganglioside, consistent with the lipid profile of the brain.
Interrogation of ganglioside synthetic precursors, in order to address where in the metabolic pathway the ganglioside elevation occurred (Fig. 1) , revealed elevations in DHC (Figs 6 and 7) . Lactosylceramide is the immediate precursor in the biosynthesis of gangliosides acted upon by G M3 synthase producing the first in the a-series, G M3 . One caveat in our mass spectrometry measurements is the assumption that DHC is predominantly lactosylceramide. As mass spectrometric detection relies on m/z ratio, it is not possible to differentiate the structural isomers, glucose and galactose, hence it cannot be ruled out that contributing to the DHC quantification may actually be any combination of two hexose residues, yielding the same m/z. Interestingly, further upstream of DHC, none of the sphingolipids, MHC, Cer or dhCer, as well as sulfatide was elevated in HS compared with WT (Table 1) . This implies tighter regulation of the sphingolipids further upstream from DHC and/or that the elevation of the simple gangliosides in HS is a direct consequence of increased concentrations of DHC feeding into the ganglioside metabolic pathway. This only appears to have an influence over the simple gangliosides G M2 , G M3 , G D2 and G D3 immediately downstream of DHC as subsequent, more complex gangliosides, G M1 and G D1 , were generally preserved. Of the five brain subregions analysed, the only exception noted was the cerebellum, in which there was elevation in the complex ganglioside, G M1 (Fig. 3) .
Our lipid characterisation of the HS mice brain is broadly in agreement with the seminal findings of Heinecke et al. (2011) -using the same mouse model -who also demonstrated increases in G M2 , G M3 and G D3 with a general preservation in other lipid species, including the ceramides and sulfatides. Discrepancies between the two data sets can largely be explained by the different methodologies employed; LC-ESI-MS/MS compared with TLC. Firstly, elevations in these ganglisoides were only observed at 12 months of age with no elevation reported at 6 months in the Heinecke et al. study. Given that these particular gangliosides are relatively minor classes within the brain, they are likely overshadowed by the more abundant gangliosides in the TLC determinations. This reasoning also likely explains our finding of elevated DHCnot specifically measured by Heinecke et al. -as this ceramide derivative is present in very low abundance in the brain and was therefore most likely masked by the more abundant brain ceramides in the TLC quantification of total ceramides. The final notable difference was our finding of increased G M1 in the cerebellum -not observed by Heinecke et al. -which is also likely a consequence of the different methods employed (LC-ESI-MS/MS vs. TLC) to quantify G M1 . Additional studies, using mass spectrometry methods enabling highly specific quantification of individual lipid species, coupled with technological advances in instrument sensitivity, will no doubt continue to add to the body of knowledge defining lipid abnormalities in HS.
Increased G M2 , G M3 , G D2 and G D3 , were apparent in HS mice at 2 months of age and although remained elevated at 6 months, there was no incremental increase. The role (if any) that elevated gangliosides play in the neurological decline manifest in HS patients remains a future topic for investigation, but their measurement following corrective therapy may be useful for assessing therapeutic benefit. G D3 in particular is prominent in reactive astrocytes, therefore implicated as a neurodegenerative marker (Seyfried and Yu 1985) and further, the observation of G M3 inducing neuronal apoptosis highlights its involvement in neuropathology (Sohn et al. 2006) . Using diet as a tool to influence ganglioside metabolism in the brain showed that LA -an essential fatty acid able to traverse the blood brain barrier -was able to significantly reduce G M2 and G M3 , but levels did not normalise to those of the WT mice (Fig. 4) . Interestingly, G D2 and G D3 were not affected by LA and it is unclear at this stage as to why only the simple gangliosides in the a-series and not the b-series were impacted. Linoleic acid also effectively reduced DHC in all brain regions of the HS mice with the exception of the cortex (Fig. 7) , and had no effect on the other sphingolipids, suggesting that its action is specific for that metabolic intermediary. It must, however, be noted that elevated lactosylceramide, being also a catabolic product, could be a reflection of general lysosomal catabolism, which may also explain the increase in some ganglioside species.
Assessment of locomotor and exploratory behaviour in the open field test showed that hypoactivity in HS mice could be improved with dietary LA supplementation (Fig. 8) . Interestingly, HS mice on the LA diet displayed an increase in activity compared to WT mice on the same diet at 6 months of age. This was not complicit with alterations in any of the sphingolipids measured, thus an explanation for this finding is currently lacking. Correcting elevated levels of the a-series of gangliosides may be achieved through LA, but further work is required to determine dose, how much reaches the brain via the digestive tract and circulation, and importantly, whether any adverse metabolic consequences arise. The only other remarkable observation was the increase in G D2 and G D3 in both the WT and HS mice on the HF diet (Fig. 5) . This was an isolated finding with no alterations in any of the other sphingolipids with the HF diet. It is noteworthy, that although we cannot rule out a possible relationship between caloric restriction/satisfaction with diet (food intake per mouse was not individually monitored because of group housing), there were no observed differences in food replenishment, which was similar across all diets. To this end, Woloszynek et al. (2009) demonstrated that HS mice had increased energy expenditure that could be partially normalised by a HF diet, suggesting that other metabolic disturbances pertaining to diet are likely confounding factors and further studies in this area are warranted.
In conclusion, we have shown that the simple gangliosides and their adjacent metabolic intermediary, DHC, are elevated in HS mice brain compared with WT. A diet high in LA was able to significantly reduce the a-series gangliosides and improve locomotor and exploratory activity behaviour. Since ganglioside accumulation occurs as early as 2 months of age, and remains elevated, ganglioside measurement following corrective therapy may be useful for assessing therapeutic benefit for the neurological manifestations of HS.
